by
Tate Herbert
| 04/29/2014
An audit of Brandeis' use of federal funding for its Prescription Drug Monitoring Program Center of Excellence claimed that $608,646 of four separate cooperative agreements-awards similar to grants-totaling $3,826,950 and awarded from 2008 to 2011, were "unallowable" or "unsupported" expenses, according to spending guidelines established by the Office of Justice Programs. The most recent award was due to end on March 31 of this year. While the audit, conducted by the Office of Justice Programs and the Office of the Inspector General, concluded that while the PDMP Center of Excellence met its goals, it recommended that Brandeis "remedy" the entirety of the questioned costs.
Annual security report gives insight into sexual assault cases at Brandeis
Manchester City found guilty of 114 of 115 charges
Brandeis begins presidential search
Christopher Nolan’s “The Odyssey” Is Not Worth 20 Years at Sea
Students for Environmental Action unveils new Brandeis Food Forest in grand opening